This Pre-Solicitation opportunity from Department Of Health And Human Services was posted on June 5, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
SUBSCRIPTION TO THE CANCER LETTER
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
The National Institutes of Health, through its Office of Logistics and Operations and the Hospital and Laboratory Support Division, intends to award a non-competitive contract for a subscription to The Cancer Letter, a weekly publication providing critical updates on cancer research, clinical trials, policy, funding, and health care legislation. The acquisition, classified under NAICS code 513120 with a size standard of $1000, is being conducted under the Federal Acquisition Regulation’s Simplified Acquisition Procedures, with a value not exceeding $350,000, and is exempt from full and open competition. The contract will provide enterprise-wide access for 3,000 to 4,000 National Cancer Institute staff, ensuring timely and unimpeded access to authoritative content essential to their mission. The acquisition is permitted under FAR 13.106-1(b)(1) for single-source procurement, citing the unique and established value of The Cancer Letter over four decades of service to the cancer research community and its direct alignment with NIH’s objectives. The solicitation number is 75N98026Q00532, posted on June 5, 2026, with a response deadline of June 15, 2026, though the original deadline stated in the document was June 1, 2026, indicating possible inconsistency. Responses must include a technical proposal, cost-price proposal, period of performance, Unique Entity ID, Taxpayer Identification Number, and business size certification, and all offerors must maintain an active registration in SAM.gov. Proposals must be submitted electronically to Roshonna Davis at davisroshonna@mail.nih.gov, with fax responses prohibited. The government retains sole discretion to proceed non-competitively based on received responses, but all responsible sources are invited to submit capability statements. The place of performance is Bethesda, Maryland, and the brand-name requirement for The Cancer Letter is explicitly affirmed under FAR 52.211-6, emphasizing the specific value of this source for the intended audience.
General Info
Agency
Contract Value
$50,000NAICS
Place of Performance
Bethesda, MD, 20892, USASet-Aside
Awardee
Award Issued Date
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Submission Closed
Organization & Contact Information
Full Description
General Information
Document Type:
Presolicitation
Synopsis Number:
75N98026Q00532
Posted Date:
June 5, 2026
Original Response Date:
June 15, 2026
Current Response Date:
June 15, 2026
Set Aside:
N/A
NAICS Code:
513120
Contracting Office Address
National Institutes of Health (NIH), Office of the Director (OD)
Office of Logistics and Operations (OLAO)
Office of Acquisition and Logistics Management (OALM)
Hospital and Laboratory Support Division
6701 Rockledge Drive
Bethesda, MD 20817
Description
INTRODUCTION
THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).
The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to:
3821 Woodley RD NW
Washington, District Of Columbia
20016-3701, United States
NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE
The intended procurement is classified under NAICS code 513120 with a Size Standard $1000.
REGULATORY AUTHORITY
The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2005-99-1, July 16, 2018. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000).
STATUTORY AUTHORITY
This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.
GENERAL INFORMATION
- Title: SUBSCRIPTION TO THE CANCER LETTER
- Background Information: The National Institutes of Health, National Cancer Institute (NCI) is the nation's leading federal agency for cancer research. This request is for a subscription to "The Cancer Letter", in an effort to provide 3,000-4,000 NCI staff swift and unencumbered access to the newsletter. The Federal Acquisition Regulation (FAR) provision FAR 52.211-6, Brand Name or Equal (AUG 1999) is applicable to this requirement. The importance of establishing enterprise-wide access to this subscription is to ensure that discoveries in NCI-supported research and clinical trials as well as information on other developments of cancer therapies, cancer research funding, health care finance, legislation and policy that impacts the work and mission of NCI. Over the past 4 decades, The Cancer Letter has provided information about cancer research, on a weekly basis, to an audience consisting of academic cancer centers, biotechnology and pharmaceutical companies, governmental agencies and other news media. The resulting journalistic outcome from this community and media partnership will be of mutual benefit to academic and community investigators, specifically, in increasing knowledge about the respective contributions and challenges in today's cancer care environment. Similar enhanced appreciation will benefit advocacy and patient stakeholders, and others in The Cancer Letter audience.
CLOSING STATEMENT
This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.
A decision by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purpose of determining whether to proceed on a non-competitive basis or to conduct competitive procurement.
All responses must be received by June 1, 2026, at 9:00 AM Eastern time and must reference solicitation number 75N98026Q00532. Responses may be submitted electronically to Roshonna Davis, Purchasing Agent at davisroshonna@mail.nih.gov Fax responses will not be accepted.
"All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.”
More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao
Same awarding agency
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 650+ contractors already using CLEATUS
